Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an ongoing
coronavirus disease (COVID-19) outbreak and a rising demand for the development of …

Pathogenic pathogens invade the human body through various pathways, causing damage
to host cells, tissues, and their functions, ultimately leading to the development of diseases …

Abstract “Test‐and‐go” single‐nucleotide variation (SNV) detection within several minutes
remains challenging, especially in low‐abundance samples, since existing methods face a …

Point-of-care (POC) HIV viral load (VL) tests are needed to enhance access to HIV VL
testing in low-and middle-income countries (LMICs) and to enable HIV VL self-testing at …

The ability to detect and quantify HIV RNA in blood is essential to sensitive detection of
infections and monitoring viremia throughout treatment. Current options for point-of-care HIV …

The COVID-19 pandemic caused by SARS-CoV-2 has drawn attention to the need for fast
and accurate diagnostic testing. Concerns from emerging SARS-CoV-2 variants and other …

The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed
an unprecedented demand for accurate and cost-effective diagnostic assays to discriminate …

Since the declaration of COVID-19 as a pandemic in early 2020, multiple variants of the
severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) have been detected …

In the context of the COVID-19 epidemic, enhancing the transport of analyte to a sensor
surface is crucial for rapid detection of biomolecules, since common conditions including low …

The COVID-19 pandemic emphasized the importance of rapid, portable, and on-site testing
technologies necessary for resource-limited settings for effective testing and screening to …